Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,148 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05828251Recruiting
Treating a fresh macular hole sooner or later
This study looks at how to manage a full-thickness macular hole that started recently, comparing different timing (“subacute” care) to see which approach helps vision best. You may be considered if your hole is small and new, and you can follow required eye positioning after treatment.
Glostrup Municipality, CopenhagenAges 18 years+ - NCT06358248Recruiting
Registry for customized endografts in complex aortic aneurysms
This registry tracks patients with complex abdominal aortic aneurysms who receive a physician-modified endograft. It aims to collect data on how well this tailored device works to treat aneurysms that standard grafts cannot handle.
PadovaAges 18–100 - NCT06363734RecruitingPhase 2
Targeted drug combo for EGFR-mutant lung cancer after resistance
This trial tests a combination of two targeted drugs (osimertinib and dalpiciclib) for people with advanced lung cancer whose tumors have a specific EGFR mutation and a change in the CDK4/6 pathway, and whose cancer has stopped responding to a third-generation EGFR targeted therapy. The goal is to see if this combination can help shrink tumors or slow cancer growth.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT06360471Recruiting
Preserving fertility in women with cancer
This study helps women with cancer keep their ability to have children after treatment. It offers egg or embryo freezing and checks on pregnancy and baby health later on.
Nanjing, JiangsuAges 20–40 - NCT06368882RecruitingPhase 4
Peg-interferon for hepatitis B with fatty liver
This trial tests a medicine called peg-interferon for people who have both chronic hepatitis B and fatty liver. It aims to see if the treatment is safe and effective in helping your body fight the hepatitis B virus.
NingboAges 18–60 - NCT06368154Recruiting
Studying early markers for brittle bones in newborns
This trial looks for tiny particles in the blood that might help doctors detect bone weakness in premature babies. It aims to find early signs of metabolic bone disease, which could lead to better care.
Changsha, HunanAges birth–3 days - NCT02434003Recruiting
Test a new way to predict scoliosis curve progression
This study follows adolescents with idiopathic scoliosis to see how well a new predictive model estimates whether the spinal curve will get worse over time. It may help doctors plan monitoring and treatment more accurately for young people with scoliosis.
San Diego, CaliforniaAges 10–15 - NCT06371586RecruitingPhase 2
Neo-Sequence 2: New drug combo for advanced stomach cancer
This trial tests a new treatment plan for advanced stomach cancer using chemotherapy, anti-angiogenesis therapy (to cut off tumor blood supply), and immunotherapy (to help your immune system fight cancer). The goal is to see if this combination works better before surgery.
BeijingAges 18–75 - NCT03373721Recruiting
Compare gut microbes in preterm vs full-term babies
This study looks at differences in the gut bacteria of babies born early (preterm) compared with babies born full-term. It may help researchers understand how early birth affects early health and gut development.
ShanghaiAges 1 day–4 months - NCT04442516Recruiting
Testing kidney injury risk from cisplatin cancer treatment
This study looks at how cisplatin chemotherapy affects the kidneys. It may help doctors better predict and protect against kidney damage when patients start cisplatin.
London, OntarioAges 3 months+ - NCT04641936Recruiting
Urine tests to predict response to immunotherapy in bladder cancer
This study uses urine “omics” tests (detailed lab patterns from urine) to predict whether immunotherapy will work for people with metastatic urothelial (bladder/urinary tract) cancer. It may help doctors choose the right treatment sooner by identifying who is more likely to benefit.
TaipeiAges 20 years+ - NCT05692778Recruiting
Care program for people with diabetes and foot problems
This trial is testing an improved care approach for people with diabetes who have foot complications, delivered through primary care. It may help by organizing care more effectively and supporting better diabetes and foot management.
GothenburgAges 18 years+ - NCT06153147Recruiting
Kidney & blood pressure in childhood cancer survivors
This study looks at kidney health and blood pressure in childhood cancer survivors. If you finished high-risk cancer therapy about 3 years ago, researchers want to see how your kidneys and blood pressure are doing now.
Toronto, OntarioAges Up to 19 years - NCT06354738Recruiting
Endometrial cancer study with genetic and surgical insights
This study looks at combining genetic testing with surgical exams to better understand endometrial cancer. It may help doctors see which treatments could work best for you.
LeuvenAges 18 years+ - NCT05817214RecruitingPhase 2
Immunotherapy plus targeted drug for advanced cervical cancer
This Phase 2 trial tests cadonilimab (an immunotherapy medicine) combined with anlotinib (a targeted drug) for advanced or recurrent cervical cancer that has already been treated. It may help shrink tumors or slow cancer growth, especially if the cancer has a measurable area doctors can track.
Wuhan, HubeiAges 18–75 - NCT06054321Recruiting
Depression medication study for adults 19 to 65
This study tests a new way of choosing antidepressants for people with major depression. It's designed for adults aged 19–65 who have moderate to severe depression and are either starting a new antidepressant or have been off psychiatric meds for at least a month.
GwangjuAges 19–65 - NCT05117723Recruiting
IPMN cyst database to help predict pancreatic cancer risk
This study collects information from people who have an IPMN cyst in the pancreas to help predict who may be at higher risk of pancreatic cancer. It may help your care team estimate risk and plan follow-up more effectively.
Fitzroy, VictoriaAges 18–90 - NCT06032676Recruiting
Surgeons’ views on infant bowel disease decisions
This study interviews surgeons who treat infants with a serious bowel condition called necrotising enterocolitis (NEC). Researchers want to understand how surgeons make decisions and how babies do afterward.
Southampton, HampshireAges Up to 4 months - NCT06224816Recruiting
Custom 3D-printed nasal masks for premature babies on breathing support
This trial tests whether custom 3D-printed nasal masks work better for premature babies who need non-invasive breathing support. The masks are made to fit each baby's face, which might be more comfortable and effective.
MadridAges birth–4 weeks - NCT06327269RecruitingEarly Phase 1
Targeted therapy after liver transplant for high-risk liver cancer
This trial tests a targeted therapy (lenvatinib) given after a living-donor liver transplant to prevent high-risk liver cancer from coming back. It is for people whose cancer is aggressive or did not respond well to previous treatments.
Kaohsiung CityAges 18–75 - NCT06375213Recruiting
Memory and thinking study for all ages
This study looks at how well people think and remember as they age. It includes healthy volunteers, people with mild memory issues, and those with dementia—both early- and late-onset.
Pathum Wan, BangkokAges 35 years+ - NCT06372743Recruiting
Nurse-led care for kidney disease with other health issues
This study tests a nurse-led care model with doctor support for people with chronic kidney disease who also have other health problems like high blood pressure or diabetes. Its goal is to help you better manage your health and avoid complications.
SingaporeAges 21 years+ - NCT05008744Recruiting
Laser treatment for twin-to-twin transfusion using one shared placenta
This study tests a laser procedure that seals abnormal blood vessel connections in identical twins sharing one placenta (twin-to-twin transfusion syndrome). The goal is to improve outcomes by stopping unbalanced blood flow between the twins.
Seattle, WashingtonAges Any age - NCT01600378Recruiting
A study to collect health data in lung disease
This study follows adults who have suspected diffuse lung disease (abnormal changes in multiple areas of the lungs) and collects health information over time. It may help doctors better understand these lung conditions and how they progress.
SingaporeAges 21–90
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,148 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.